These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 9929506

  • 1. Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous and oral administration to rats: hepatic and gastric first-pass effects.
    Han KS, Lee MG.
    Drug Metab Dispos; 1999 Feb; 27(2):221-6. PubMed ID: 9929506
    [Abstract] [Full Text] [Related]

  • 2. Hepatic and intestinal first-pass effects of oltipraz in rats.
    Bae SK, Kim JW, Kim YH, Kim YG, Kim SG, Lee MG.
    Biopharm Drug Dispos; 2005 May; 26(4):129-34. PubMed ID: 15744718
    [Abstract] [Full Text] [Related]

  • 3. Dose-independent pharmacokinetics of clindamycin after intravenous and oral administration to rats: contribution of gastric first-pass effect to low bioavailability.
    Yang SH, Lee MG.
    Int J Pharm; 2007 Mar 06; 332(1-2):17-23. PubMed ID: 17157458
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous administration to rabbits.
    Han KS, Woo SJ, Koo CH, Lee MG.
    Res Commun Mol Pathol Pharmacol; 1998 Apr 06; 100(1):29-34. PubMed ID: 9644716
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic changes of intravenous 2-(allylthio) pyrazine, a chemoprotective agent, in rats with acute renal failure induced by uranyl nitrate.
    Lee EJ, Kim EJ, Kim YG, Chung HC, Kim SH, Kim DH, Lee I, Kim SG, Lee MG.
    Res Commun Mol Pathol Pharmacol; 2002 Apr 06; 111(5-6):225-36. PubMed ID: 15244038
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dose-independent pharmacokinetics of ondansetron in rats: contribution of hepatic and intestinal first-pass effects to low bioavailability.
    Yang SH, Lee MG.
    Biopharm Drug Dispos; 2008 Oct 06; 29(7):414-26. PubMed ID: 18697186
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of ipriflavone, an isoflavone derivative, after intravenous and oral administration to rats hepatic and intestinal first-pass effects.
    Kim SH, Lee MG.
    Life Sci; 2002 Feb 01; 70(11):1299-315. PubMed ID: 11883708
    [Abstract] [Full Text] [Related]

  • 13. Interspecies pharmacokinetic scaling of oltipraz in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.
    Bae SK, Lee SJ, Kim YG, Kim SH, Kim JW, Kim T, Lee MG.
    Biopharm Drug Dispos; 2005 Apr 01; 26(3):99-115. PubMed ID: 15723427
    [Abstract] [Full Text] [Related]

  • 14. Dose-independent pharmacokinetics of a candidate for diabetic neuropathy, SR-4668, after intravenous and oral administration to rats: Intestinal first-pass effect.
    Kim EJ, Bae SK, Kim HJ, Kim YG, Kim SO, Lee DH, Lim H, Lee MG.
    J Pharm Sci; 2003 May 01; 92(5):1112-24. PubMed ID: 12712431
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.